Regeneron
Tarrytown, New York, United States · Biotechnology, Health Care, Science And Engineering
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Tarrytown, New York, United States
- Employees
- 17,048
- Industries
- Biotechnology, Health Care, Science And Engineering
- Status
- Public (REGN)
- Website
- www.regeneron.com
Recent activity at Regeneron
- : Regeneron partners with Parabilis to develop a new class of drug worth up to $2.3 billion. (date Fundz recorded it)
- : Regeneron Pharmaceuticals Expands U.S. Capacity With US$3 Billion Fujifilm Partnership (date Fundz recorded it)
- : Regeneron Pharmaceuticals Achieves Sixth Year on Dow Jones Sustainability World Index Reflecting Commitment to Responsible Practices
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Employee benefit plans
Regeneron files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About Regeneron: questions and answers
What does Regeneron do?
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown
Where is Regeneron headquartered?
Regeneron is headquartered in Tarrytown, New York, United States.
How many employees does Regeneron have?
Regeneron has about 17,048 employees.
What is the latest news on Regeneron?
On May 18, 2026, Regeneron partners with Parabilis to develop a new class of drug worth up to $2.3 billion.
Is Regeneron a public company?
Yes. Regeneron is publicly traded under the ticker REGN.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy